| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/29/2006 | EP1222266B1 Pca3 messenger rna in benign and malignant prostate tissues |
| 03/29/2006 | EP1218024B1 Aspartame derivatives for decreasing blood viscosity |
| 03/29/2006 | EP1181376B1 Gene construct for prodrug activation encoding a heterologous, glycosylphophatidylinositol-modified carboxypeptidase g2 and a cell surface targeting signal peptide |
| 03/29/2006 | EP1165050B1 Methods for fine powder formation |
| 03/29/2006 | EP1115742B1 Purification of fibrinogen from milk by use of cation exchange chromatography |
| 03/29/2006 | EP1086224B1 B2 microglobulin fusion proteins and high affinity variants |
| 03/29/2006 | EP1079847B1 Osteoporosis treatment |
| 03/29/2006 | EP1036090B1 Echinocandin derivatives, preparation method and application as anti-fungal agents |
| 03/29/2006 | EP1005490B1 Zinc free insulin crystals for use in pulmonary compositions |
| 03/29/2006 | EP1003786B1 Peptide with radio protective effect |
| 03/29/2006 | EP0990031B1 Tumor necrosis factor receptor 5 |
| 03/29/2006 | EP0973518B1 Semi-synthetic studies toward didemnin analogues |
| 03/29/2006 | EP0948541B1 Analogs of PTHrP |
| 03/29/2006 | EP0946715B1 Use of a modified protein c |
| 03/29/2006 | EP0944722B1 Pituitary-tumor-transforming-genes, and related products |
| 03/29/2006 | EP0918797B1 Humanized immunoglobulin reactive with alpha4beta7 integrin |
| 03/29/2006 | EP0833925B1 Diagnostic test for equine arteritis virus mediated disease |
| 03/29/2006 | EP0751709B2 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |
| 03/29/2006 | CN1754002A Methods and compositions concerning poxviruses and cancer |
| 03/29/2006 | CN1753909A Peptides and pharmaceutical compositions comprising said peptides and medical composition for treating cancer |
| 03/29/2006 | CN1753694A Remedy for spinal injury containing interleukin-6 antagonist |
| 03/29/2006 | CN1753693A Uses of anti-insulin-like growth factor I receptor antibodies |
| 03/29/2006 | CN1753690A Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation |
| 03/29/2006 | CN1753689A The use of cytochrome p450 enzyme cyp2wi as a drug traget for cancer therapy |
| 03/29/2006 | CN1753688A Night-time oral insulin therapy |
| 03/29/2006 | CN1753687A Use of cpg oligonucleotides in the treatment of hepatitis c virus infection |
| 03/29/2006 | CN1753686A Methods, compositions and kits for promoting recovery from damage to the central nervous system |
| 03/29/2006 | CN1753685A Anticancer agent comprising lk8 protein as an active ingredient |
| 03/29/2006 | CN1753684A Improved antitumoral treatments |
| 03/29/2006 | CN1753683A Ophthalmic formulation for the prevention and treatment of ocular conditions |
| 03/29/2006 | CN1753682A Herbal compositions for prostate conditions |
| 03/29/2006 | CN1753662A Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 03/29/2006 | CN1752211A Recombination targent fused protein for treating acquired immunodeficiency syndrome |
| 03/29/2006 | CN1752210A Chicken interferon gamma, preparing process and use thereof |
| 03/29/2006 | CN1752102A Technology of preparing rat nerve growth factor using organic solvent virus deactivation method |
| 03/29/2006 | CN1752101A Protein separated from jellyfish and possessing antioxygenation activity and its application |
| 03/29/2006 | CN1752100A Marine organism anticancer protein and its extraction method |
| 03/29/2006 | CN1751740A Medicinal composition for treating arthritis |
| 03/29/2006 | CN1751739A Use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia |
| 03/29/2006 | CN1247782C Actinia neurotoxin gene and its application |
| 03/29/2006 | CN1247781C Actinia neurotoxin gene and its application |
| 03/29/2006 | CN1247780C Mammalian sytokine-like polypeptide-10 |
| 03/29/2006 | CN1247616C New monomeric insulin, its medicinal composition and prepn process |
| 03/29/2006 | CN1247613C Novel omega-conotoxin peptides |
| 03/29/2006 | CN1247541C Cyclic imines as pesticides |
| 03/29/2006 | CN1247260C Analogs of parathyroid hormone |
| 03/29/2006 | CN1247259C Recombinant human interferon alpha spray |
| 03/29/2006 | CN1247258C Combination therapy using anti-angiogenic agents and TNF alpha |
| 03/29/2006 | CN1247257C Stable erythropoietin of recombined human red blood cell |
| 03/29/2006 | CN1247256C Pharmaceutical combination for treatment of tissue damage owing to arterial irrigation defect |
| 03/29/2006 | CN1247255C Preparation of biochemical nutrients for ostrich |
| 03/29/2006 | CN1247254C Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 03/29/2006 | CN1247205C Sea cucumber carotenoid lipid fraction products and method of use |
| 03/29/2006 | CN1247183C Dental products comprising bone growth enhancing peptide |
| 03/28/2006 | USRE39048 substitution of the sixth amino acid Glycine of the LHRH (luteinizing hormone releasing hormone) decapeptide by D-Lysine or D-Glutamine; the resulting variant peptide is coupled to a common carrier and/or mild adjuvant; immunocastration; mammals |
| 03/28/2006 | US7019193 Treatments using transgenic goat produced antithrombin III |
| 03/28/2006 | US7019192 Composition for filling bone defects |
| 03/28/2006 | US7019125 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 03/28/2006 | US7019123 Human bikunin |
| 03/28/2006 | US7019119 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
| 03/28/2006 | US7019118 Antiinflammatory agents; rheumatic disease |
| 03/28/2006 | US7019116 PRO 1387 polypeptides |
| 03/28/2006 | US7019115 Nucleotide sequences coding membrane protein for use as antiproliferative/antitumor/antiinflammatory/anticarcinogenic agents |
| 03/28/2006 | US7019111 Glycosylated ligand/receptor specificity exchangers specific for bacterial adhesion receptors |
| 03/28/2006 | US7019110 Streptogramin derivatives, preparation method and compositions containing same |
| 03/28/2006 | US7019108 Especially the amino acid sequence Ile-Phe-Ala-Gly-Asp-Lys-Phe-Trp-Arg, preferably flanked by cysteine residues at the amino and carboxy termini. |
| 03/28/2006 | US7019023 Benzothiepine 1, 1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
| 03/28/2006 | US7018996 Bactericides, antiseptic; Streptomyces culture; peptide antibiotics |
| 03/28/2006 | US7018985 Composition and method for inhibiting platelet aggregation |
| 03/28/2006 | US7018982 Methods useful in the treatment of bone resorption diseases |
| 03/28/2006 | US7018981 Gastrointestinal disorders |
| 03/28/2006 | US7018980 Dissolving drug in acidic aqueous buffered solution; adding surfactant and oil; agitation; oral administering |
| 03/28/2006 | US7018979 simultaneous administration of agonist and anticarcinogenic agent; potassium channel agonist is not bradykinin or a bradykinin analog, but can be a guanylyl cyclase activator, a guanylyl cyclase activating protein, minoxidil, pinacidil, cromakalim, or levcromakalim |
| 03/28/2006 | US7018841 Compositions and methods for the inhibition of neurotransmitter uptake of synaptic vesicles |
| 03/28/2006 | US7018839 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator |
| 03/28/2006 | US7018832 Transport proteins for use in the treatment and diagnosis of stroke, pain, neuropathic pain and traumatic brain injury |
| 03/28/2006 | US7018825 DNase liquid solutions |
| 03/28/2006 | US7018822 Guanosine monophosphate reductase |
| 03/28/2006 | US7018814 Process of purifying vancomycin hydrochloride |
| 03/28/2006 | US7018810 Chordin-like molecules and uses thereof |
| 03/28/2006 | US7018803 Inhibitors of collagen assembly |
| 03/28/2006 | US7018654 Pharmaceutical composition containing an active agent in an amino acid copolymer structure |
| 03/28/2006 | US7018653 Method for preparing solid dosage form of desmopressin |
| 03/28/2006 | US7018645 biodegradable and water soluble polyesterether block polymers used for drug delivery |
| 03/28/2006 | US7018633 Selective destruction of cells infected with human immunodeficiency virus |
| 03/28/2006 | US7018631 Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
| 03/28/2006 | US7018630 administering subtilisins obtained from grampositive bacterial residues that vitamin k2 has been removed using chitosan |
| 03/28/2006 | US7018626 Chimeric IL-10 |
| 03/28/2006 | US7018609 For drug delivery |
| 03/28/2006 | CA2415750C Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 03/28/2006 | CA2395186C Procollagen c-proteinase inhibitors |
| 03/28/2006 | CA2291892C Angiostatin fragments and method of use |
| 03/28/2006 | CA2278744C Continuous microsphere process |
| 03/28/2006 | CA2252229C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components |
| 03/28/2006 | CA2106719C Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 03/28/2006 | CA2096723C Methods and compositions for the suppression of neu mediated transformation |
| 03/23/2006 | WO2006032016A2 P49/strap is a novel protein involved in gene regulation and cell proliferation |
| 03/23/2006 | WO2006031980A2 Treatment for cancer-related fatigue |
| 03/23/2006 | WO2006031885A2 Kdr and vegf/kdr binding peptides |
| 03/23/2006 | WO2006031811A2 Glycopegylated interferon alpha |